They evidenced that the downregulation of the lncRNA NKILA and NBAT1 are linked to tumor size, whereas the blood concentration of H19 and SPRY4-IT1 is a good parameter to discriminate between BC patients and controls. The gene discussed is NBAT1; the disease is breast cancer.